Diane M. Diehl | Authors

Waters Corporation


A Strategic Approach to the Quantification of Therapeutic Peptides in Biological Fluids

The growing market for biotherapeutic peptides and the development of quantitative methods for those analytes has brought to light the challenges facing the analysis of this broad range of compounds. Market forces and regulatory requirements are encouraging analytical groups to develop methodologies that are time- and cost-effective, while still producing assays that are sensitive enough to cope with biological matrices.